Spatial immune scoring and prediction of HCC outcomes

Spatial immune scoring and prediction of HCC outcomes

Saved in:

Bibliographic Details
Main Authors:	Marta Piqué-Gili, Daniela Sia
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	JHEP Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555925001545
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

P-18 ANTI-HBC POSITIVITY IS AN INDEPENDENT PREDICTIVE FACTOR FOR HCC DEVELOPMENT AND SHOULD BE INCORPORATED TO THE HCC RISK SCORE PREDICTION MODEL IN ADVANCED FIBROSIS
by: Marcus Vinicius de Acevedo Garcia Gomes, et al.
Published: (2024-12-01)

The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC
by: Tao Sun, et al.
Published: (2025-03-01)

Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC
by: Hee Sun Cho, et al.
Published: (2025-06-01)

Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapy
by: Pei-Chang Lee, et al.
Published: (2025-09-01)

Associations between the SMARS score derived from CT and MRI with histopathological features in HCC
by: Daniele Romeo, et al.
Published: (2025-07-01)

Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis
by: Fu X, et al.
Published: (2025-05-01)

Integrated single-cell and bulk transcriptome analysis of R-loop score-based signature with regard to immune microenvironment, lipid metabolism and prognosis in HCC
by: Long Chen, et al.
Published: (2025-01-01)

Immunotherapy and MASLD-Related HCC: Should We Reconsider the Role of Etiology in the Therapeutic Approach to HCC?
by: Giuseppina Vizioli, et al.
Published: (2025-02-01)

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC
by: Rahul Deshpande, et al.
Published: (2011-01-01)

Correction: Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score
by: Xiaopeng Yu, et al.
Published: (2025-07-01)

Evolving epidemiology of HCC in Spain
by: Margarita Sala, et al.
Published: (2025-05-01)

Plasma proteomic signature for preoperative prediction of microvascular invasion in HCC
by: Xinrui Shi, et al.
Published: (2025-09-01)

The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs
by: Zerun Lin, et al.
Published: (2025-07-01)

An Evidence-Based Multidisciplinary Approach to the Management of Hepatocellular Carcinoma (HCC): The Alberta HCC Algorithm
by: Kelly W Burak, et al.
Published: (2010-01-01)

From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapy
by: Lei Xu, et al.
Published: (2025-05-01)

Machine Learning Model Based on Prognostic Nutritional Index for Predicting Long‐Term Outcomes in Patients With HCC Undergoing Ablation
by: Nan Zhang, et al.
Published: (2024-10-01)

Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study
by: Cheng Zhang, et al.
Published: (2025-07-01)

Ultrasound-guided percutaneous microwave ablation for metabolic-associated fatty liver disease-related hepatocellular carcinoma (HCC) versus hepatitis virus B-related HCC: a propensity score matching study
by: Yannan Qiao, et al.
Published: (2024-12-01)

Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC
by: Yu Huang, et al.
Published: (2025-06-01)

Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC
by: Shouge Zang, et al.
Published: (2025-07-01)

Classification of Signature-Based Phenotypes of Aging-Related Genes to Identify Prognostic and Immune Characteristics in HCC
by: Junjie Zhao, et al.
Published: (2023-01-01)

HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies
by: Fouad Jaber, et al.
Published: (2025-12-01)

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
by: Meng Wu, et al.
Published: (2025-02-01)

Hypoxia-related signatures predicts survival, immunosuppression and PARP inhibitor resistance in HCC
by: Min Su, et al.
Published: (2025-06-01)

HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies
by: Carmelo Laface, et al.
Published: (2025-02-01)

A nomogram for prognostic prediction and for therapeutic decision making of elderly HCC patients
by: Shuyu Liu, et al.
Published: (2025-04-01)

Exposure of Bisphenols (BPs) to hepatocellular carcinoma (HCC) patients and non-HCC patients: Association with liver function biomarkers
by: Shibo Li, et al.
Published: (2024-12-01)

Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition
by: Nazareno Gonzalez, et al.
Published: (2025-05-01)

Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors
by: Wei SM, et al.
Published: (2025-06-01)

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
by: Wu L, et al.
Published: (2025-01-01)

SBRT for bridging and downstaging HCC before transplant
by: Zhihao Li, et al.
Published: (2025-08-01)

Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
by: Man Yao, et al.
Published: (2022-01-01)

Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
by: Chen X, et al.
Published: (2025-03-01)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
by: Tommaso Mello, et al.
Published: (2016-01-01)

Macroscopic Portal Vein Thrombosis in HCC Patients
by: Hikmet Akkiz, et al.
Published: (2018-01-01)

SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
by: Ying-Ming Xu, et al.
Published: (2025-07-01)

Single-cell sequencing and machine learning reveal the role of dioxin-interacting genes in HCC prognosis and immune microenvironment
by: Senyan Wang, et al.
Published: (2025-07-01)

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC
by: Zhenyun Yang, et al.
Published: (2024-12-01)

Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages
by: Zhenwei Song, et al.
Published: (2024-12-01)

Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation
by: Neehar D. Parikh, et al.
Published: (2025-12-01)